ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
14
views
0
references
Top references
cited by
0
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,096
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Integrated Safety Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura
Author(s):
Paul Knobl
,
Marie Scully
,
Spero R. Cataland
,
Flora Peyvandi
,
Paul Coppo
,
Johanna Kremer Hovinga
,
Ara Metjian
,
Javier de la Rubia
,
Katerina Pavenski
,
Jessica Minkue
,
Filip Callewaert
,
Hilde De Winter
Publication date:
2018
Journal:
Blood
Read this article at
ScienceOpen
Publisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Scientific Ocean Drilling Expedition Research Results
Author and article information
Journal
DOI::
10.1182/blood-2018-99-112174
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
3,096
Real-world evidence of caplacizumab use in the management of acute TTP
Authors:
T Dutt
,
R.J. Shaw
,
M.J. Stubbs
…
Thrombotic thrombocytopenic purpura temporally associated with BNT162b2 vaccination in an adolescent successfully treated with caplacizumab
Authors:
A Kirpalani
,
J Garabon
,
K. Amos
New therapeutic targets and treatment options for thrombotic microangiopathy: caplacizumab and ravulizumab
Authors:
C. CHUNG
See all similar